Cons: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with inoperable large volume stage III non-small cell lung cancer

被引：1
|
作者：
Rodrigues, George [1 ]
机构：
[1] London Hlth Sci Ctr, Dept Radiat Oncol, A3-808,790 Commissioners Rd E, London, ON, Canada
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2016年 / 5卷 / 02期
关键词：
PHASE-III; RTOG; 0617; RADIOTHERAPY; TRIAL; CHEMORADIATION; THERAPY;
D O I：
10.21037/tlcr.2016.04.03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：195 / 197
页数：3
相关论文
共 50 条
  • [41] Radiotherapy for medically inoperable non-small cell lung cancer at clinical stage I and II
    Yamada, K
    Soejima, T
    Ota, Y
    Sasaki, R
    Yoden, E
    Kanaoka, N
    Maruta, T
    Sugimura, K
    TUMORI, 2003, 89 (01) : 75 - 79
  • [42] Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)-a German radiation oncology survey
    Kaesmann, Lukas
    Eze, Chukwuka
    Taugner, Julian
    Roengvoraphoj, Olarn
    Belka, Claus
    Manapov, Farkhad
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (02) : 288 - 293
  • [43] Gender Difference in Treatment Outcomes in Patients with Stage III Non-small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy
    Sekine, Ikuo
    Sumi, Minako
    Ito, Yoshinori
    Tanai, Chiharu
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Kunitoh, Hideo
    Ohe, Yuichiro
    Tamura, Tomohide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (11) : 707 - 712
  • [44] Combined chemotherapy and radiotherapy in inoperable non-small cell lung cancer
    Jassem, J
    LUNG CANCER, 2002, 38 : S43 - S46
  • [45] Outcomes treating stage III non-small cell lung carcinoma with curative-intent radiotherapy and concurrent carboplatin-paclitaxel chemotherapy
    Hon Trinh
    Pinkham, Mark Blayne
    Lehman, Margot
    Zarate, Dannie
    Dauth, Margaret
    McGrath, Margaret
    McCaffrey, Elizabeth
    Mai, Gang Tao
    Horwood, Keith
    CLINICAL RESPIRATORY JOURNAL, 2016, 10 (04): : 428 - 434
  • [46] Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer
    Taugner, Julian
    Eze, Chukwuka
    Kaesmann, Lukas
    Roengvoraphoj, Olarn
    Gennen, Kathrin
    Karin, Monika
    Petrukhnov, Oleg
    Tufman, Amanda
    Belka, Claus
    Manapov, Farkhad
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [47] Locoregional tumor failure after definitive radiation for patients with stage III non-small cell lung cancer
    Rajpara, Raj S.
    Schreibmann, Eduard
    Fox, Tim
    Stapleford, Liza J.
    Beitler, Jonathan J.
    Curran, Walter J.
    Higgins, Kristin A.
    RADIATION ONCOLOGY, 2014, 9
  • [48] Advances in the Treatment of Stage III Non-Small Cell Lung Cancer
    Myall, Nathaniel J.
    Das, Millie
    CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 211 - +
  • [49] Therapeutic revolution for inoperable stage III non-small cell lung cancer in the immune era
    Li, Jiakang
    Xu, Jingyan
    Yang, Mingyi
    Zhou, Qing
    CANCER BIOLOGY & MEDICINE, 2022, 19 (05) : 569 - 572
  • [50] Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review
    Rowell, NP
    Williams, CJ
    THORAX, 2001, 56 (08) : 628 - 638
12345